Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 391492, 8 pages
http://dx.doi.org/10.1155/2014/391492
Research Article

Association of Myeloid Cells of Triggering Receptor-1 with Left Ventricular Systolic Dysfunction in BALB/c Mice with Sepsis

Department of Critical Care Medicine, Affiliated Hospital of Guangdong Medical College, No. 57 Southern Renmin Avenue, Zhanjiang, Guangdong 524023, China

Received 29 January 2014; Revised 20 April 2014; Accepted 1 May 2014; Published 15 May 2014

Academic Editor: Elaine Hatanaka

Copyright © 2014 Gaosheng Zhou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. J. Bulmer, “Cardiovascular dysfunction in sepsis and citical illness,” Veterinary Clinics of North America: Small Animal Practice, vol. 41, no. 4, pp. 717–726, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. J. E. Parrillo, M. M. Parker, C. Natanson et al., “Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy,” Annals of Internal Medicine, vol. 113, no. 3, pp. 227–242, 1990. View at Google Scholar · View at Scopus
  3. J. N. Pulido, B. Afessa, M. Masaki et al., “Clinical spectrum, frequency, and significance of myocardial dysfunction in severe sepsis and septic shock,” Mayo Clinic Proceedings, vol. 87, no. 7, pp. 620–628, 2012. View at Publisher · View at Google Scholar
  4. M. W. Merx and C. Weber, “Sepsis and the heart,” Circulation, vol. 116, no. 7, pp. 793–802, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. O. Court, A. Kumar, J. E. Parrillo, and A. Kumar, “Clinical review: myocardial depression in sepsis and septic shock,” Critical Care, vol. 6, no. 6, pp. 500–508, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. A. S. Tessarz and A. Cerwenka, “The TREM-1/DAP12 pathway,” Immunology Letters, vol. 116, no. 2, pp. 111–116, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Colonna and F. Facchetti, “TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses,” Journal of Infectious Diseases, vol. 187, no. 2, pp. S397–S401, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Bouchon, J. Dietrich, and M. Colonna, “Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes,” Journal of Immunology, vol. 164, no. 10, pp. 4991–4995, 2000. View at Google Scholar · View at Scopus
  9. A. Bouchon, F. Facchetti, M. A. Weigand, and M. Colonna, “TREM-1 amplifies inflammation and is a crucial mediator of septic shock,” Nature, vol. 410, no. 6832, pp. 1103–1107, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Tao, L. Peng, L. Deng, Y. Shao, L. Deng, and H. Yao, “Association of serum myeloid cells of soluble triggering receptor-1 level with myocardial dysfunction in patients with severe sepsis,” Mediators of Inflammation, vol. 2013, Article ID 819246, 6 pages, 2013. View at Publisher · View at Google Scholar
  11. S. Gibot, M.-N. Kolopp-Sarda, M.-C. Béné et al., “A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis,” Journal of Experimental Medicine, vol. 200, no. 11, pp. 1419–1426, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Ha, C. Lu, L. Liu et al., “TLR2 ligands attenuate cardiac dysfunction in polymicrobial sepsis via a phosphoinositide 3-kinase-dependent mechanism,” American Journal of Physiology: Heart and Circulatory Physiology, vol. 298, no. 3, pp. H984–H991, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Ha, F. Hua, D. Grant et al., “Glucan phosphate attenuates cardiac dysfunction and inhibits cardiac MIF expression and apoptosis in septic mice,” American Journal of Physiology: Heart and Circulatory Physiology, vol. 291, no. 4, pp. H1910–H1918, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Baumgarten, P. Knuefermann, N. Nozaki, N. Sivasubramanian, D. L. Mann, and J. G. Vallejo, “In vivo expression of proinflammatory mediators in the adult heart after endotoxin administration: the role of toll-like receptor-4,” Journal of Infectious Diseases, vol. 183, no. 11, pp. 1617–1624, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Bozkurt, S. B. Kribbs, F. J. Clubb Jr. et al., “Pathophysiologically relevant concentrations of tumor necrosis factor- α promote progressive left ventricular dysfunction and remodeling in rats,” Circulation, vol. 97, no. 14, pp. 1382–1391, 1998. View at Google Scholar · View at Scopus
  16. M. M. Parker, K. E. McCarthy, F. P. Ognibene, and J. E. Parrillo, “Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans,” Chest, vol. 97, no. 1, pp. 126–131, 1990. View at Google Scholar · View at Scopus
  17. A. G. Ellrodt, M. S. Riedinger, and A. Kimchi, “Left ventricular performance in septic shock: reversible segmental and global abnormalities,” American Heart Journal, vol. 110, no. 2, pp. 402–409, 1985. View at Google Scholar · View at Scopus
  18. C. J. Wiggers, “Myocardial depression in shock. A survey of cardiodynamic studies,” American Heart Journal, vol. 33, no. 5, pp. 633–650, 1947. View at Google Scholar · View at Scopus
  19. T. M. Balija and S. F. Lowry, “Lipopolysaccharide and sepsis-associated myocardial dysfunction,” Current Opinion in Infectious Diseases, vol. 24, no. 3, pp. 248–253, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Dejager and C. Libert, “Tumor necrosis factor alpha mediates the lethal hepatotoxic effects of poly(I:C) in d-galactosamine-sensitized mice,” Cytokine, vol. 42, no. 1, pp. 55–61, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. D. A. Russell, K. K. Tucker, N. Chinookoswong, R. C. Thompson, and T. Kohno, “Combined inhibition of interleukin-1 and tumor necrosis factor in rodent endotoxemia: improved survival and organ function,” Journal of Infectious Diseases, vol. 171, no. 6, pp. 1528–1538, 1995. View at Google Scholar · View at Scopus
  22. I. Takeyoshi, D. Yoshinari, M. Kobayashi, M. Kurabayashi, and Y. Morishita, “A dual inhibitor of TNF-α and IL-1 mitigates liver and kidney dysfunction and improves survival in rat endotoxemia,” Hepato-Gastroenterology, vol. 52, no. 65, pp. 1507–1510, 2005. View at Google Scholar · View at Scopus
  23. S. Gibot, F. Massin, M. Marcou et al., “TREM-1 promotes survival during septic shock in mice,” European Journal of Immunology, vol. 37, no. 2, pp. 456–466, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. R. J. Ulevitch and P. S. Tobias, “Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin,” Annual Review of Immunology, vol. 13, pp. 437–457, 1995. View at Google Scholar · View at Scopus
  25. R. L. Modlin, H. D. Brightbill, and P. J. Godowski, “The toll of innate immunity on microbial pathogens,” The New England Journal of Medicine, vol. 340, no. 23, pp. 1834–1835, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. R. J. Ulevitch, “Endotoxin opens the tollgates to innate immunity,” Nature Medicine, vol. 5, no. 2, pp. 144–145, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Aderem and R. J. Ulevitch, “Toll-like receptors in the induction of the innate immune response,” Nature, vol. 406, no. 6797, pp. 782–787, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Gibot, “Clinical review: role of triggering receptor expressed on myeloid cells-1 during sepsis,” Critical Care, vol. 9, no. 5, pp. 485–489, 2005. View at Publisher · View at Google Scholar · View at Scopus